Bankruptcy News

We've summarized the latest docket activity and news for publicly traded companies currently operating under U.S. Bankruptcy Court protection.

Bankruptcy/Chapter 11

PhaseRx Chapter 11 Petition Filed

PhaseRx filed for Chapter 11 protection with the U.S. Bankruptcy Court in the District of Delaware, case number 17-12890. The Company, which develops pharmaceuticals focused on the treatment of inherited enzyme deficiencies in the liver, is represented by Christopher A. Ward of Polsinelli. PhaseRx announced its intentions to continue to manage and operate its business. The Company is working with Cowen and Company to "review financial and strategic alternatives with the goal of maximizing stockholder value." Robert W. Overell, Ph.D., president and C.E.O. of PhaseRx, comments, "The protection afforded under a Chapter 11 filing enables us to continue to explore strategic alternatives, including a potential merger transaction."

Read more Bankruptcy News